Mesh : Humans Adjuvants, Immunologic / therapeutic use Toll-Like Receptors / agonists metabolism immunology Vaccines / immunology Animals

来  源:   DOI:10.1126/scitranslmed.adq5644

Abstract:
Adjuvants that combine TLR agonists and inflammatory agonists promote robust and durable vaccine responses (Bechtold et al. and Arunachalam et al.).
摘要:
结合TLR激动剂和炎性激动剂的佐剂促进稳健和持久的疫苗应答(Bechtold等人。和Arunachalam等人。).
公众号